This review concluded that the risk of uterine rupture was similar in women with and without a prior caesarean delivery who used misoprostol (prostaglandin analogue) for second-trimester abortion. The authors' conclusions appeared to reflect the limited evidence available but, given the limitations with the review process and the uncertain quality of the included studies, they should be interpreted with caution.
Study selection
Studies that assessed the use of misoprostol for second-trimester abortion in women with prior caesarean delivery were eligible for inclusion. Eligible studies had to report the frequency of uterine rupture (as defined in the review) in women with and without previous caesarean delivery. Case reports, narrative reviews, and commentaries were excluded.
The included studies were carried out in 11 different countries. Included women had a history of at least one caesarean delivery or no previous caesarean delivery (including women with previous vaginal delivery and women who had not given birth). Where reported, women were between 10 and 28 weeks gestation. Misoprostol regimens varied, with most studies administering a dose between 200 and 400 micrograms, either orally, vaginally or sublingually. Some studies used additional techniques/treatments to induce abortion or evacuate incomplete abortion.
One reviewer screened relevant articles for inclusion.
Assessment of study quality
The author did not state that they assessed validity.
Data extraction
One reviewer extracted data on the number of uterine ruptures to calculate the risk of rupture, the 95% confidence intervals (CIs), and the number needed to harm.
Methods of synthesis
Estimates of risk and the 95% confidence intervals were pooled, but the methods were not reported. Further analyses appear to have been undertaken to assess the effects of using misoprostol alone or with another method for labour induction.
